Kiaie, S.H and Asadzadeh, Z and Baradaran, B and Jafari, R and Hadidi, S and Azimi, I and Heshmati, M and Sanaei, M.J (2020) Immune checkpoints in targetedimmunotherapy of pancreatic cancer: New hope for clinical development. Acta Pharmaceutica Sinica B. pp. 1-15.
|
Text
2253.pdf Download (941kB) | Preview |
Abstract
Immunotherapy has been recently considered as a promising alternative for cancer treatment. Indeed, targeting of immune checkpoint (ICP) strategies have shown significant success in human malignancies. However, despite remarkable success of cancer immunotherapy in pancreatic cancer (PCa), many of the developed immunotherapy methods show poor therapeutic outcomes in PCa with no or few effective treatment options thus far. In this process, immunosuppression in the tumor microenvironment (TME) is found to be the main obstacle to the effectiveness of antitumor immune response induced by an immunotherapy method. In this paper, the latest findings on the ICPs, which mediate immunosuppression in the TME have been reviewed. In addition, different approaches for targeting ICPs in the TME
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Immune checkpoint; Pancreatic cancer; Tumor microenvironment; Immunotherapy; Clinical development |
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Unnamed user with email gholipour.s@umsu.ac.ir |
| Date Deposited: | 26 Jun 2021 05:38 |
| Last Modified: | 26 Jun 2021 05:38 |
| URI: | http://eprints.umsu.ac.ir/id/eprint/6252 |
Actions (login required)
 |
View Item |
